SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-462790
Filing Date
2013-12-05
Accepted
2013-12-05 07:02:00
Documents
9
Period of Report
2013-12-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d638339d8k.htm 8-K 15726
2 EX-99.1 d638339dex991.htm EX-99.1 97374
3 GRAPHIC g638339ex99_1s1gbgd.jpg GRAPHIC 28247
4 GRAPHIC g638339ex99_1s2gbgd.jpg GRAPHIC 11016
5 GRAPHIC g638339ex99_1s3gbgd.jpg GRAPHIC 14788
6 GRAPHIC g638339ex99_1s4gbgd.jpg GRAPHIC 68754
7 GRAPHIC g638339ex99_1s5gbgd.jpg GRAPHIC 41003
8 GRAPHIC g638339ex99_1s6gbgd.jpg GRAPHIC 37658
9 GRAPHIC g638339ex99_1s7gbgd.jpg GRAPHIC 23707
  Complete submission text file 0001193125-13-462790.txt   425797
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 131258690
SIC: 2834 Pharmaceutical Preparations